Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Christoph Höeller, Olivier Michielin, Paolo A. Ascierto, et al.
Cancer Immunology Immunotherapy (2016) Vol. 65, Iss. 9, pp. 1015-1034
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

A new dawn for eosinophils in the tumour microenvironment
Sharon Grisaru‐Tal, Michal Itan, Amy D. Klion, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 10, pp. 594-607
Closed Access | Times Cited: 239
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Nicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 851-864
Open Access | Times Cited: 140
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 101
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 93
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
Margaret E. Gatti‐Mays, Jason M. Redman, Julie Collins, et al.
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 11, pp. 2561-2574
Open Access | Times Cited: 102
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara M. Mangsbo, Divya Nagarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 95
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
Lillian Sun, Pauline Funchain, Jung Min Song, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 93
The Peptide Vaccine of the Future
Annika Nelde, Hans‐Georg Rammensee, Juliane S. Walz
Molecular & Cellular Proteomics (2020) Vol. 20, pp. 100022-100022
Open Access | Times Cited: 80
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
Howard Donninger, Chi Li, John W. Eaton, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 668-668
Open Access | Times Cited: 60
Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research
Helena Kupcová Skalníková, Jana Čížková, Jakub Červenka, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2697-2697
Open Access | Times Cited: 76
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Reinhard Dummer, Christoph Höeller, Isabella Pezzani Grüter, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 6, pp. 683-695
Open Access | Times Cited: 64
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
Khaphetsi Joseph Mahasa, Amina Eladdadi, Lisette de Pillis, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0184347-e0184347
Open Access | Times Cited: 58
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
Elena García-Martínez, Melody Smith, Aitziber Buqué, et al.
OncoImmunology (2018) Vol. 7, Iss. 6
Open Access | Times Cited: 50
Personalized cancer vaccines: adjuvants are important, too
Cécile Gouttefangeas, Hans‐Georg Rammensee
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 12, pp. 1911-1918
Open Access | Times Cited: 50
Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy
Xiaoyue Yang, Jiansheng Fan, Yue Wu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 37, pp. 102443-102443
Closed Access | Times Cited: 36
Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza
Elizabeth Q. Littauer, Lisa K. Mills, Nicole Brock, et al.
Journal of Controlled Release (2018) Vol. 276, pp. 1-16
Open Access | Times Cited: 44
Perspectives on immunotherapy via oncolytic viruses
Alberto Reale, Adriana Vitiello, Valeria Conciatori, et al.
Infectious Agents and Cancer (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Role of the β Common (βc) Family of Cytokines in Health and Disease
Timothy R. Hercus, Winnie L. Kan, Sophie E. Broughton, et al.
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 6, pp. a028514-a028514
Open Access | Times Cited: 38
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
Mark R. Middleton, Christoph Höeller, Olivier Michielin, et al.
British Journal of Cancer (2020) Vol. 123, Iss. 6, pp. 885-897
Open Access | Times Cited: 30
MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer
Michelle M. Williams, Jessica L. Christenson, Kathleen O’Neill, et al.
npj Breast Cancer (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 27
A purified acidic polysaccharide from Sarcandra glabra as vaccine adjuvant to enhance anti-tumor effect of cancer vaccine
Wei Liu, Xingqun Gong, Jianhua Luo, et al.
Carbohydrate Polymers (2021) Vol. 263, pp. 117967-117967
Closed Access | Times Cited: 24
Cellular Markers of Immunosuppression in Sepsis
Arturo Cérbulo Vázquez, Lourdes Arriaga‐Pizano, Eduardo Ferat‐Osorio
Archives of Medical Research (2021) Vol. 52, Iss. 8, pp. 828-835
Closed Access | Times Cited: 24
Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review)
Qiujun Zhou, Tingting Fang, Shenyu Wei, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 17
Intercellular crosstalk in human malignant melanoma
Barbora Dvořánková, Pavol Szabó, Ondřej Kodet, et al.
PROTOPLASMA (2016) Vol. 254, Iss. 3, pp. 1143-1150
Closed Access | Times Cited: 29
Antitumor Peptide-Based Vaccine in the Limelight
Takumi Kumai, Hidekiyo Yamaki, Michihisa Kono, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 70-70
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top